UK markets closed

Chugai Pharmaceutical Co., Ltd. (4519.T)

Tokyo - Tokyo Delayed price. Currency in JPY
Add to watchlist
4,953.00-42.00 (-0.84%)
At close: 03:15PM JST
Currency in JPY

Valuation measures4

Market cap (intra-day) 8.15T
Enterprise value 7.39T
Trailing P/E 24.97
Forward P/E 22.47
PEG ratio (5-yr expected) 5.26
Price/sales (ttm)7.87
Price/book (mrq)4.96
Enterprise value/revenue 7.13
Enterprise value/EBITDA 16.63

Trading information

Stock price history

Beta (5Y monthly) 0.51
52-week change 316.90%
S&P500 52-week change 323.76%
52-week high 36,697.00
52-week low 33,767.00
50-day moving average 34,984.98
200-day moving average 35,150.36

Share statistics

Avg vol (3-month) 32.38M
Avg vol (10-day) 31.94M
Shares outstanding 51.65B
Implied shares outstanding 61.66B
Float 8639.35M
% held by insiders 159.91%
% held by institutions 118.77%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 482
Forward annual dividend yield 41.66%
Trailing annual dividend rate 380.00
Trailing annual dividend yield 31.60%
5-year average dividend yield 41.72
Payout ratio 440.33%
Dividend date 3N/A
Ex-dividend date 427 Jun 2024
Last split factor 23:1
Last split date 329 Jun 2020

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 31.50%
Operating margin (ttm)42.15%

Management effectiveness

Return on assets (ttm)15.01%
Return on equity (ttm)21.20%

Income statement

Revenue (ttm)1.04T
Revenue per share (ttm)629.73
Quarterly revenue growth (yoy)-24.10%
Gross profit (ttm)N/A
EBITDA 472.39B
Net income avi to common (ttm)326.37B
Diluted EPS (ttm)198.12
Quarterly earnings growth (yoy)1.20%

Balance sheet

Total cash (mrq)764.57B
Total cash per share (mrq)464.67
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)5.53
Book value per share (mrq)997.97

Cash flow statement

Operating cash flow (ttm)383.09B
Levered free cash flow (ttm)287.01B